Summary
Dengning Xia is an Associate Professor and pharmaceutical scientist with over a decade of experience translating oral drug formulations from bench to clinic, having advanced multiple candidates through preclinical development to regulatory approval for human trials. He combines deep expertise in formulation science, solid-state characterization, and analytical method development with hands-on experience in scaling manufacturing processes across non-GLP, GLP and GMP settings. His work spans sustained-release systems, poorly soluble drug strategies, and nano/microparticle platforms (nanocrystals, liposomes, microspheres), and he applies DMPK and IVIVC modeling via GastroPlus to link formulation to in vivo performance. Dengning has authored 30+ peer-reviewed papers with 800+ citations and serves as an expert reviewer for more than ten journals, reflecting both scholarly impact and peer recognition. Notably, he has led successful tech-transfer and quality standard establishment for multiple IND-enabling programs and holds funded grants from national agencies, demonstrating a rare blend of academic rigor and practical product development. Based in Shenzhen, he brings proven leadership in mentoring teams and managing cross-disciplinary projects that bridge academic research and regulatory-driven drug development.
10 years of coding experience
6 years of employment as a software developer
Master's degree, Pharmaceutical Sciences, Master's degree, Pharmaceutical Sciences at Sichuan University
Doctor of Philosophy (Ph.D.), Pharmaceutical Sciences, Doctor of Philosophy (Ph.D.), Pharmaceutical Sciences at Shenyang Pharmaceutical University
Guest PhD student, Pharmaceutical Sciences, Guest PhD student, Pharmaceutical Sciences at Københavns Universitet - University of Copenhagen